Skip to main content
Clinical Trials/ACTRN12617000271303
ACTRN12617000271303
Completed
未知

Feasibility and efficacy of using lung inflammation and mechanics measurements to predict respiratory complications during general anaesthesia for young children with and without asthma.

Prof Britta Regli-von Ungern-Sternberg0 sites120 target enrollmentFebruary 22, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Prof Britta Regli-von Ungern-Sternberg
Enrollment
120
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 22, 2017
End Date
December 16, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Prof Britta Regli-von Ungern-Sternberg

Eligibility Criteria

Inclusion Criteria

  • Children, aged 4 to 10 years of age, male and female, undergoing elective surgery under general anaesthesia at our site.
  • Test group:
  • 1 or more respiratory risk factors:
  • \*Wheeze (more than or equal to 3 times) over past year
  • \*Recurrent respiratory symptoms during exercise in the past year
  • \*Persistent dry cough in last 12 months
  • Control group:
  • \*No doctor diagnosed active respiratory symptoms as listed in test group
  • \*Can have family history of:
  • \*Hay fever

Exclusion Criteria

  • \*Cystic Fibrosis, bronchiectasis (doctor diagnosed conditions)
  • \*Cardiac or Thoracic surgery
  • \*Doctor diagnosed cardiac diseases
  • \*Known major Syndromes
  • \*Use of ketamine or midazolam premedication
  • \*Contraindication to the use of sevoflurane
  • \*Less than 32 weeks gestational age
  • \*Recent cold

Outcomes

Primary Outcomes

Not specified

Similar Trials